These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22320997)

  • 41. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
    Murata M; Tagawa M; Kimura H; Kakisawa K; Shirasawa H; Fujisawa T
    Int J Oncol; 1998 Mar; 12(3):577-81. PubMed ID: 9472095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between smoking and p53 mutation in lung cancer: a meta-analysis.
    Liu X; Lin XJ; Wang CP; Yan KK; Zhao LY; An WX; Liu XD
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):18-24. PubMed ID: 24126199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
    Sanchez-Cespedes M; Decker PA; Doffek KM; Esteller M; Westra WH; Alawi EA; Herman JG; Demeure MJ; Sidransky D; Ahrendt SA
    Cancer Res; 2001 Mar; 61(5):2092-6. PubMed ID: 11280771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.
    Hasegawa Y; Ando M; Maemondo M; Yamamoto S; Isa S; Saka H; Kubo A; Kawaguchi T; Takada M; Rosell R; Kurata T; Ou SH
    Oncologist; 2015 Mar; 20(3):307-15. PubMed ID: 25657199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rationale and design of the Japan molecular epidemiology for lung cancer study.
    Kawaguchi T; Ando M; Ito N; Isa S; Tamiya A; Shimizu S; Saka H; Kubo A; Koh Y; Matsumura A
    Clin Lung Cancer; 2013 Sep; 14(5):596-600. PubMed ID: 23685138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lung Adenocarcinoma in Never Smokers: Problems of Primary Prevention from Aspects of Susceptible Genes and Carcinogens.
    Okazaki I; Ishikawa S; Ando W; Sohara Y
    Anticancer Res; 2016 Dec; 36(12):6207-6224. PubMed ID: 27919939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lung cancer in never smokers: change of a mindset in the molecular era.
    Lee YJ; Kim JH; Kim SK; Ha SJ; Mok TS; Mitsudomi T; Cho BC
    Lung Cancer; 2011 Apr; 72(1):9-15. PubMed ID: 21272954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.
    Toyooka S; Maruyama R; Toyooka KO; McLerran D; Feng Z; Fukuyama Y; Virmani AK; Zochbauer-Muller S; Tsukuda K; Sugio K; Shimizu N; Shimizu K; Lee H; Chen CY; Fong KM; Gilcrease M; Roth JA; Minna JD; Gazdar AF
    Int J Cancer; 2003 Jan; 103(2):153-60. PubMed ID: 12455028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer.
    Sanz-Ortega J; Roig F; Al-Mousa MM; Saez MC; Muñoz A; Sanz-Esponera J; Callol L
    Histol Histopathol; 2007 May; 22(5):541-5. PubMed ID: 17330809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.
    Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P
    Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Lung cancer in smokers and never-smokers].
    Helland A; Brustugun OT
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1859-62. PubMed ID: 19844277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke.
    Hainaut P; Pfeifer GP
    Carcinogenesis; 2001 Mar; 22(3):367-74. PubMed ID: 11238174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
    Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
    Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations.
    Husgafvel-Pursiainen K; Karjalainen A; Kannio A; Anttila S; Partanen T; Ojajärvi A; Vainio H
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):667-74. PubMed ID: 10100998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genotoxicity of environmental tobacco smoke: a review.
    Husgafvel-Pursiainen K
    Mutat Res; 2004 Nov; 567(2-3):427-45. PubMed ID: 15572289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.
    Kim DH; Kim JS; Ji YI; Shim YM; Kim H; Han J; Park J
    Cancer Res; 2003 Jul; 63(13):3743-6. PubMed ID: 12839968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-small cell lung cancer with EML4-ALK translocation in Chinese male never-smokers is characterized with early-onset.
    Guo Y; Ma J; Lyu X; Liu H; Wei B; Zhao J; Fu S; Ding L; Zhang J
    BMC Cancer; 2014 Nov; 14():834. PubMed ID: 25407901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
    Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
    Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.
    Devarakonda S; Li Y; Martins Rodrigues F; Sankararaman S; Kadara H; Goparaju C; Lanc I; Pepin K; Waqar SN; Morgensztern D; Ward J; Masood A; Fulton R; Fulton L; Gillette MA; Satpathy S; Carr SA; Wistuba I; Pass H; Wilson RK; Ding L; Govindan R
    J Clin Oncol; 2021 Nov; 39(33):3747-3758. PubMed ID: 34591593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Epidemiological Study on Passive Smoking and Estrogen Receptor Expression in Never-smokers with Non-small Cell Lung Cancer.
    Naoki Y; Kawaguchi T; Isa SI; Shimizu S; Tamiya A; Asai K; Kudoh S; Hirata K
    Osaka City Med J; 2016 Dec; 62(2):77-84. PubMed ID: 30721582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.